Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


03.12.2018

1 AIDS
1 Am J Med
1 Dig Dis Sci
6 J Hepatol
1 J Infect Dis
1 J Med Virol
1 J Virol
1 Lancet
2 Lancet Gastroenterol Hepatol
3 PLoS One
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. LOAREC A, Carnimeo V, Molfino L, Kizito W, et al
    Extremely Low Hepatitis C prevalence among HIV co-infected individuals in 4 countries in sub-Saharan Africa.
    AIDS. 2018 Nov 16. doi: 10.1097/QAD.0000000000002070.
    PubMed     Text format     Abstract available


    Am J Med

  2. MERA J, Reilley B, Leston J, Stephens D, et al
    In a Critical State: Ongoing Barriers to Treatment for Hepatitis C Virus (HCV).
    Am J Med. 2018 Nov 23. pii: S0002-9343(18)31072.
    PubMed     Text format    


    Dig Dis Sci

  3. CHEN LY, Fan XP, Fan YC, Zhao J, et al
    BATF Interference Blocks Th17 Cell Differentiation and Inflammatory Response in Hepatitis B Virus Transgenic Mice.
    Dig Dis Sci. 2018 Nov 29. pii: 10.1007/s10620-018-5392.
    PubMed     Text format     Abstract available


    J Hepatol

  4. COSTA R, Todt D, Zapatero-Belinchon F, Schenk C, et al
    SEC14L2, a lipid-binding protein, regulate HCV replication in culture with inter- and intra- genotype variations.
    J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32544.
    PubMed     Text format     Abstract available

  5. PHILIPS CA, Augustine P, Padsalgi G, Ahamed R, et al
    Only in the darkness can you see the stars: Severe alcoholic hepatitis and higher grades of acute-on-chronic liver failure.
    J Hepatol. 2018 Nov 20. pii: S0168-8278(18)32456.
    PubMed     Text format    

  6. RASCHE A, Sander AL, Corman VM, Drexler JF, et al
    Evolutionary biology of human hepatitis viruses.
    J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32542.
    PubMed     Text format     Abstract available

  7. D'AMBROSIO R, Pasulo L, Puoti M, Vinci M, et al
    Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C.
    J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32543.
    PubMed     Text format     Abstract available

  8. VAN SEYEN M, Smolders EJ, van Wijngaarden P, Drenth JPH, et al
    Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring.
    J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32492.
    PubMed     Text format    

  9. MODIN L, Arshad A, Wilkes B, Benselin J, et al
    Epidemiology and natural history of hepatitis C virus infection among children and young people.
    J Hepatol. 2018 Nov 26. pii: S0168-8278(18)32545.
    PubMed     Text format     Abstract available


    J Infect Dis

  10. PIROZYAN MR, Nguyen N, Cameron B, Luciani F, et al
    Chemokine-regulated recruitment of antigen-specific T cell sub-populations to the liver in acute and chronic hepatitis C infection.
    J Infect Dis. 2018 Nov 29. pii: 5213654. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  11. TRIPATHY AS, Puranik S, Sharma M, Chakraborty S, et al
    Hepatitis E Virus Seroprevalence among Blood Donors in Pune, India.
    J Med Virol. 2018 Nov 29. doi: 10.1002/jmv.25370.
    PubMed     Text format     Abstract available


    J Virol

  12. VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
    Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms.
    J Virol. 2018 Nov 28. pii: JVI.01909-18. doi: 10.1128/JVI.01909.
    PubMed     Text format     Abstract available


    Lancet

  13. SETO WK, Lo YR, Pawlotsky JM, Yuen MF, et al
    Chronic hepatitis B virus infection.
    Lancet. 2018;392:2313-2324.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  14. FLANAGAN S, Kunkel J, Appleby V, Eldridge SE, et al
    Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2018 Nov 23. pii: S2468-1253(18)30318.
    PubMed     Text format     Abstract available

  15. HICKMAN M, Mandel S, Vickerman P, Miners A, et al
    Hepatitis case finding among migrants in primary care.
    Lancet Gastroenterol Hepatol. 2018 Nov 23. pii: S2468-1253(18)30385.
    PubMed     Text format    


    PLoS One

  16. KHAN B, Duncan I, Saad M, Schaefer D, et al
    Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment.
    PLoS One. 2018;13:e0206356.
    PubMed     Text format     Abstract available

  17. BUTI M, Dominguez-Hernandez R, Casado MA, Sabater E, et al
    Healthcare value of implementing hepatitis C screening in the adult general population in Spain.
    PLoS One. 2018;13:e0208036.
    PubMed     Text format     Abstract available

  18. CHOWDHURY P, Sahuc ME, Rouille Y, Riviere C, et al
    Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture.
    PLoS One. 2018;13:e0198226.
    PubMed     Text format     Abstract available


    Virology

  19. GRIERSON SS, McGowan S, Cook C, Steinbach F, et al
    Molecular and in vitro characterisation of hepatitis E virus from UK pigs.
    Virology. 2018;527:116-121.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: